Cargando…

Deep Brain Stimulation in the Treatment of Tardive Dyskinesia

Tardive dyskinesia (TD) is a phenomenon observed following the predominantly long-term use of dopamine receptor blockers (antipsychotics) widely used in psychiatry. TD is a group of involuntary, irregular hyperkinetic movements, mainly in the muscles of the face, eyelid, lips, tongue, and cheeks, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szczakowska, Adrianna, Gabryelska, Agata, Gawlik-Kotelnicka, Oliwia, Strzelecki, Dominik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003252/ https://www.ncbi.nlm.nih.gov/pubmed/36902655 http://dx.doi.org/10.3390/jcm12051868

Ejemplares similares

Probiotics as a Treatment for “Metabolic Depression”? A Rationale for Future Studies
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2021)

Ghrelin as a Biomarker of “Immunometabolic Depression” and Its Connection with Dysbiosis
por: Gajewska, Agata, et al.
Publicado: (2023)

“Leaky Gut” as a Keystone of the Connection between Depression and Obstructive Sleep Apnea Syndrome? A Rationale and Study Design
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2022)

Adiposity in Depression or Depression in Adiposity? The Role of Immune-Inflammatory-Microbial Overlap
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2021)

Tardive Dyskinesia: Treatment with Aripiprazole
por: Kang, Na-Ri, et al.
Publicado: (2011)

The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms; Function and Composition of Gut Microbiota; and Metabolic, Inflammation, and Oxidative Stress Markers in Patients with Depression—A Study Protocol
por: Skowrońska, Anna, et al.
Publicado: (2023)

PRO-DEMET Randomized Controlled Trial on Probiotics in Depression—Pilot Study Results
por: Gawlik-Kotelnicka, Oliwia, et al.
Publicado: (2023)

Treatment of neurolept-induced tardive dyskinesia
por: Jankelowitz, Stacey K
Publicado: (2013)

Pathophysiology, prognosis and treatment of tardive dyskinesia
por: Takeuchi, Hiroyoshi, et al.
Publicado: (2022)

Comparison of thyroid-stimulating hormone levels in adolescents with schizophrenia, bipolar disorder, unipolar depression, conduct disorders, and hyperkinetic disorders
por: Makarow-Gronert, Agnieszka, et al.
Publicado: (2021)

New and emerging treatments for symptomatic tardive dyskinesia
por: Rana, Abdul Qayyum, et al.
Publicado: (2013)

An Update on Tardive Dyskinesia: From Phenomenology to Treatment
por: Waln, Olga, et al.
Publicado: (2013)

METOCLOPRAMIDE IN TARDIVE DYSKINESIA
por: Hemanani, T.J., et al.
Publicado: (1983)

Recent Advances in the Pharmacology of Tardive Dyskinesia
por: Caroff, Stanley N.
Publicado: (2020)

Case report: Pallidal deep brain stimulation for treatment of tardive dystonia/dyskinesia secondary to chronic metoclopramide medication
por: Nagel, Johanna M., et al.
Publicado: (2023)

Copulatory Dyskinesia: Pathognomonic Manifestation of Tardive Dyskinesia
por: Sharma, Vibhash D., et al.
Publicado: (2020)

Resilience and Psychological Well-Being of Polish Women in the Perinatal Period during the COVID-19 Pandemic
por: Sójta, Klaudia, et al.
Publicado: (2023)

Improvement of Tardive Dyskinesias with Olanzapine
por: Echater, S., et al.
Publicado: (2023)

Dysphagia due to tardive dyskinesia
por: Bhat, Pookala S., et al.
Publicado: (2010)

RISK FACTORS FOR TARDIVE DYSKINESIA
por: Datta, Sunil, et al.
Publicado: (1994)

PESISTENT PARKINSONISM AND TARDIVE DYSKINESIA
por: Shaji, K.S., et al.
Publicado: (1995)

Amoxapine-induced tardive dyskinesia
por: Singh, Gurvinder Pal
Publicado: (2009)

Reversibility of Tardive Dyskinesia Syndrome
por: Vinuela, Angel, et al.
Publicado: (2014)

Amisulpride Reexposure and Tardive Dyskinesia
por: Sidana, Ajeet
Publicado: (2018)

Tardive Dyskinesia Associated with Bupropion
por: Tuman, Taha Can, et al.
Publicado: (2017)

Clozapine-induced Tardive Dyskinesia
por: Das, Soumitra, et al.
Publicado: (2017)

Relevance of animal models to human tardive dyskinesia
por: Blanchet, Pierre J, et al.
Publicado: (2012)

Overcoming barriers to effective management of tardive dyskinesia
por: Caroff, Stanley N
Publicado: (2019)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome, Leslie, et al.
Publicado: (2021)

Tardive dyskinesia with clozapine dose reduction or withdrawal dyskinesia?
por: Praharaj, Samir Kumar
Publicado: (2011)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019)

TETRABNAZINE FOR ISOLATED SHOULDER TARDIVE DYSKINESIA
por: Basu, Soumya, et al.
Publicado: (2001)

LOW DOSE LEVODOPA IN TARDIVE DYSKINESIA
por: Sethi, Sujata, et al.
Publicado: (1990)

Tardive dyskinesia with low dose amisulpride
por: Tharoor, Hema, et al.
Publicado: (2013)

Facial mask masking tardive dyskinesia
por: Ganhao, I.
Publicado: (2021)

Putative role of immune reactions in the mechanism of tardive dyskinesia
por: Loonen, Anton J.M.
Publicado: (2023)

Tardive dyskinesia: understanding current challenges in diagnosis and treatment
por: Taylor, David, et al.
Publicado: (2023)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Recognition and Treatment of Tardive Dyskinesia in Individuals with Intellectual Disability
por: Morton, Robert O., et al.
Publicado: (2020)

Supplementation of Antipsychotic Treatment with the Amino Acid Sarcosine Influences Proton Magnetic Resonance Spectroscopy Parameters in Left Frontal White Matter in Patients with Schizophrenia
por: Strzelecki, Dominik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sah0lhahqnit7rip9ukirdn1ub